Compare AMSF & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMSF | CTKB |
|---|---|---|
| Founded | 1985 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.3M | 541.1M |
| IPO Year | 1996 | 2021 |
| Metric | AMSF | CTKB |
|---|---|---|
| Price | $29.12 | $4.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $46.33 | $5.63 |
| AVG Volume (30 Days) | 227.0K | ★ 752.8K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.61% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $317,252,000.00 | $193,015,000.00 |
| Revenue This Year | $8.45 | $5.42 |
| Revenue Next Year | $6.03 | $7.03 |
| P/E Ratio | $24.57 | ★ N/A |
| Revenue Growth | 2.66 | ★ 17.67 |
| 52 Week Low | $28.94 | $3.28 |
| 52 Week High | $47.86 | $6.18 |
| Indicator | AMSF | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 38.52 |
| Support Level | $29.46 | $4.13 |
| Resistance Level | $32.11 | $4.49 |
| Average True Range (ATR) | 0.93 | 0.18 |
| MACD | -0.23 | -0.05 |
| Stochastic Oscillator | 14.06 | 17.83 |
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.